Survival Bump With EGFR Inhibitor for KRAS Wild-Type Pancreatic Cancer But generalizability of "notable" Chinese study questioned Jun 03, 2022
T-Cell Receptor Gene Therapy Shows Promise in Pancreatic Cancer Novel treatment targeting KRAS G12D expression induces deep and durable response Jun 01, 2022
Increased Public Assistance Tied to Better Cancer Survival in Black Patients Disparity in 5-year OS declined by more than 40% with each 10% boost in public welfare spending May 31, 2022
Is U.S. 'Getting Its Money's Worth' When It Comes to Cancer Care? Cost/mortality benefit pales in comparison with other high-income countries, according to study May 31, 2022
COVID Increased Use of Telemedicine for Cancer Care, Though Not Equitably Black, uninsured, non-urban patients less likely to use these services May 26, 2022
Robotic Surgery Wins for Keeping Bladder Cancer Patients Alive, Out of Hospital Approach bested open surgery in iROC trial, but is the difference clinically important? May 15, 2022
Combo Treatment Scores Big in BCG-Unresponsive Bladder Cancer Significantly durable response with VesAnktiva-Bacillus Calmette-Guérin duo May 15, 2022
Concerning Spike in Barrett's Esophagus, Esophageal Cancer in Middle-Age Adults Should these patients undergo screening, especially if they have risk factors? May 15, 2022
Could Gallstone Disease Predict Pancreatic Cancer? Researchers urge more attention to gallstone disease patients with atypical symptoms May 13, 2022
Oral Retinoid May Ease Painful Skin Reactions to Anticancer Therapy Preliminary data on acitretin therapy are promising May 11, 2022
Young Cancer Survivors Face Higher Risk of Death From Second Malignancies Study finds 25% higher risk of secondary cancers versus general public, 84% higher risk of death May 04, 2022
Corticosteroids Linked to Pain Events in Patients With Sickle Cell Disease Hospitalization risk for vaso-occlusive episodes four times higher after exposure May 02, 2022
Longer Ischemia Time Not Tied to Higher Complication Rate in Free-Tissue Transfer Main focus of microvascular surgery should be best possible H&N reconstruction, researchers say May 01, 2022
Ambient Dirty Air May Put Some People at Higher Risk for Head and Neck Cancers Diesel particulate levels tied to increased oral and pharyngeal cancer incidence in one state May 01, 2022
Immunotherapy Before Head and Neck Surgery Doesn’t Add to Complications Definitive surgery can be conducted safely after neoadjuvant immunotherapy, researchers conclude May 01, 2022
Another Robotic Approach for Bladder Cancer Removal Proves Its Mettle Robot-assisted laparoscopy with ICUD tied to better survival versus open surgery Apr 29, 2022
Program to Reduce Opioid Scripts Post-Surgery Worked for Thyroid Cancer Patients Post-surgical intervention may help to reduce the risk of opioid addiction and overdose Apr 29, 2022
New Guidelines Target Cancer Risk in Rare GI Syndromes Task force focuses on diagnosis, management of gastrointestinal hamartomatous polyposis syndromes Apr 28, 2022
When Free Flaps Fail Twice, Another Try Can Be Successful Second salvage attempt worked in 30% of cases Apr 28, 2022
Topical Antisepsis May Thwart SSIs in Upper Aerodigestive Tract Reconstruction Preoperative topical antisepsis mucosal preparation associated with 51% fewer infections Apr 28, 2022
Stop Calling It Cancer; AI Gets a Win in Bladder Cancer; Lack of Price Transparency News, features, and commentary about cancer-related issues Apr 22, 2022
Anti-CD39 Combination Therapy Promising in Gastric/GEJ Cancer Responses in a majority of patients, evidence of durability with TTX-030, chemoimmunotherapy Apr 14, 2022
PARP Inhibitor-Based Triplet Promising in Endometrial Cancer Olaparib/cyclophosphamide/metformin combo appears effective in older, heavily pretreated patients Apr 11, 2022
New Clue to Risk of Peritoneal Cancer After Prophylactic Salpingo-Oophorectomy Women with BRCA variant and serous tubal intraepithelial carcinoma had a 34-fold greater risk Apr 05, 2022
Black Patients More Often Get 'Substandard' Care for GI Cancers Retrospective study finds worse surgical outcomes, lower odds of receiving chemotherapy Apr 04, 2022
Triplet Induction Regimen Bests Doublet for Nasopharyngeal Carcinoma Three drugs reduced risk of disease failure, but longer follow-up needed to assess OS Mar 25, 2022
Artificial Sweeteners Not So Sweet When It Comes to Cancer Risk Consumption of certain sugar alternatives linked to a 13% higher risk of developing cancer Mar 24, 2022
Intraperitoneal Carboplatin Boosts PFS in Ovarian Cancer Should the gynecologic oncology community reconsider IP therapy? Mar 22, 2022
Lenvatinib Packaging for Endometrial Cancer Tied to $168 Million in Overspending Presenter breaks news at SGO that drug developer commits to overhauling dose reduction program Mar 20, 2022
Selinexor Proves Mettle in Advanced or Recurrent Endometrial Cancer Benefit was greatest among patients with wild-type p53 cancer in SIENDO trial Mar 20, 2022
Fecal Microbiome Markers Detect Pancreatic Cancer With 'High Accuracy' These markers need to be tested in a prospective cohort before clinical impact can be determined Mar 10, 2022
Robotic Hepatectomy Shows Benefits Over Laparoscopic Surgery Shorter hospital stay, similar perioperative outcomes in matched analysis Mar 10, 2022
Radioiodine for Low-Risk Thyroid Cancer: Yea or Nay? Randomized study finds no meaningful difference in events of abnormalities between groups Mar 09, 2022
Another Casualty of COVID-19: Evidence-Based Medicine Physician laments decline in research quality, critical appraisal during pandemic Mar 09, 2022
Cancer May Heighten Odds of Guillain-Barre Syndrome Link strongest with hematologic malignancies as well as prostate, breast, and respiratory cancers Mar 03, 2022
ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
Kids With IBD Need Close Monitoring as They Grow Up Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
Novel Therapies Active in Head and Neck Cancers High response rate with oncolytic virus plus immunotherapy in cutaneous lesions Feb 28, 2022
AI Platform Near Perfect for Predicting Thyroid Malignancy High precision for T stage, extracapsular extension, BRAF mutation Feb 27, 2022
PD-L1 Inhibitor Fails to Meet PFS Target in Advanced Penile Cancer Atezolizumab did show some activity, with a 30% overall response rate Feb 22, 2022
